SCHEMBL6132259

SCHEMBL6132259

COC1CCC(C2CCC(O)CC2)CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
SHBG P04278 1/20 0.31
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10876165 1.00 TSHR (0.32) TSHRSHBGEPHX2
SCHEMBL2368898 0.92
SCHEMBL2369051 0.92
SCHEMBL473550 0.92
Hydrogen Peroxide SCHEMBL28037399 0.89 TSHR (0.35) TSHRSHBGEPHX2
SCHEMBL4547601 0.86 EPHX2 (0.31) EPHX2
SCHEMBL14720917 0.82 TSHR (0.43) TSHRSHBG
SCHEMBL17547356 0.78
SCHEMBL21420110 0.77
SCHEMBL7077398 0.76 TSHR (0.50) TSHRSHBGEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025057-B1 THERMAL INSULATING COATING BASF SE (DE) 2017-08-23 EP disclosed
US-9541690-B2 Film using polymerizable liquid crystal composition containing peeling preventive agent JNC CORPORATION (JP) 2017-01-10 US disclosed
WO-2016114347-A1 POLYMERIZABLE COMPOSITION AND OPTICALLY ANISOTROPIC BODY USING SAME DIC株式会社 2016-07-21 WO disclosed
WO-2016114348-A1 POLYMERIZABLE COMPOSITION AND OPTICALLY ANISOTROPIC MATERIAL DIC株式会社 2016-07-21 WO disclosed
US-20140308462-A1 FILM USING POLYMERIZABLE LIQUID CRYSTAL COMPOSITION CONTAINING PEELING PREVENTIVE AGENT JNC PETROCHEMICAL CORPORATION (JP) 2014-10-16 US disclosed
US-20140049738-A1 THREE-DIMENSIONAL IMAGE DISPLAY APPARATUS JNC PETROCHEMICAL CORPORATION (JP) 2014-02-20 US disclosed
US-8425988-B2 Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer JNC CORPORATION (JP) 2013-04-23 US disclosed
US-6884774-B2 Cyclic hexapeptide derivatives FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-04-26 US disclosed
EP-1259535-B1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-04-13 EP disclosed
US-20030083238-A1 Cyclic hexapeptide derivatives ASTELLAS PHARMA INC. (JP) 2003-05-01 US disclosed
US-4631328-A LIQUID CRYSTALS BASF AKTIENGESELLSCHAFT (DE) 1986-12-23 US disclosed
EP-0090282-B1 POLYMERS HAVING MESOGEN GROUPS AND COLOURING MATTER IN THE SIDE CHAIN BASF Aktiengesellschaft (DE) 1986-02-05 EP disclosed
EP-0090282-A1 Polymers having mesogen groups and colouring matter in the side chain BASF Aktiengesellschaft (DE) 1983-10-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083238-A1 Cyclic hexapeptide derivatives NGLY1, ALG1, CHIT1 TSHR 3037/4885SHBG 4088/4885EPHX2 4723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.